How will the acceleration of China's manufacturing industry's digital transformation affect the pharmaceutical industry?

[ Market analysis of chemical machinery equipment network ] In recent years, China's manufacturing industry is developing continuously.
Statistics show that in the first quarter of 2021, my country's equipment manufacturing industry has maintained a rapid growth momentum, and its added value has increased by 9.
9% year-on-year.
However, it is worth noting that the traditional production model of my country's manufacturing industry has also begun to be increasingly challenged since 2020.
The industry believes that in this context, the urgency and importance of the industry's digital transformation will become more prominent.
Especially in 2021, under the influence of various factors such as individualized customer demand, rapid increase in export orders, and overcapacity, Chinese manufacturing companies need to further increase their investment in digital transformation.

As an important part of the manufacturing industry, how will the pharmaceutical equipment industry be affected and how will it develop under the background of accelerating the digital transformation of China's manufacturing industry? Industry analysts believe that, as an important part of the manufacturing industry, the rapid digital transformation of the pharmaceutical equipment industry is actually imminent.
It is understood that since 2020, major pharmaceutical companies have increased their investment in digital construction.
In 2019, digitization-related costs accounted for 23% of pharmaceutical companies with more than 10% of total product input costs, and this proportion has reached 40% in March 2020.

In fact, it can be seen from the above data that with the continuous introduction of medical reform policies and increasingly fierce market competition, pharmaceutical companies are increasing digital construction and accelerating digital transformation is becoming the norm in the industry.
As the pharmaceutical equipment industry, which is closely related to the pharmaceutical industry, naturally also needs to cooperate with its common development.
In fact, in recent years, the digital development of the pharmaceutical equipment industry has been supported by many policies.

As recently, the "14th Five-Year Plan for Intelligent Manufacturing Development" drafted by the Ministry of Industry and Information Technology in conjunction with relevant departments proposed that by 2025, manufacturing enterprises above designated size will be basically digitized, and key industries in key industries will initially realize intelligent transformation.
By 2035, digitalization will be popularized among manufacturing enterprises above designated size, and backbone enterprises will basically realize intelligent transformation.
In addition, "Made in China 2025" also proposed to accelerate the development of a new generation of information technology and the integration of manufacturing technology, take intelligent manufacturing as the main direction of the deep integration of the two, and promote my country's manufacturing model from "Made in China" to "China "Intelligent manufacturing" changes.

At present, with the continuous promotion of relevant policies, many domestic pharmaceutical equipment companies have actively invested in accelerating digital upgrades.
For example, a pharmaceutical equipment company is using digital chromatography systems to shorten the manufacturing cycle of pharmaceutical equipment hardware, create, store, and call mature formula technology to ensure the stability and reproducibility of pharmaceutical processes, and enable the design and manufacturing of pharmaceutical equipment More standardized and modular.

 

There are also pharmaceutical equipment companies that choose to deepen the intelligent manufacturing of pharmaceutical equipment and build "smart and smart pharmaceutical factories" through acquisitions and establishment of subsidiaries, and accelerate their entry into the "Era of Pharmaceutical Industry 4.
0".
Among them, in terms of digitization, as the authenticity requirements of the production process data become more and more stringent, the company grasps hardware with one hand and software products with the other.
It has been able to automatically monitor the production and circulation of pharmaceuticals online in real time, and it can automatically Generate data that cannot be tampered with, realize automatic reading of data, and store data in the cloud to avoid delays, dead ends, and blind spots.

In addition, some companies are committed to providing overall solutions for pharmaceutical companies, including the entire life cycle of project services from early conceptual design to later project implementation, on-site installation and commissioning, and verification services.
Among them, the company’s overall smart oral preparation solution developed for the production of oral liquid preparations consists of five core functional modules: digital extraction workshop, automated preparation workshop, robotic packaging workshop, three-dimensional warehouse and logistics system for raw and auxiliary materials, and informatization and data center.
Composition, through the industrial Internet, as well as high-efficiency and energy-saving process equipment systems and robot production lines, the interconnection and efficient coordination of the entire process from extraction to product packaging have been realized.

On the whole, the rapid digital transformation of the pharmaceutical equipment industry has become a trend.
The industry believes that through continuous digital transformation of pharmaceutical equipment companies, on the one hand, it will help improve management efficiency and reduce corporate costs, on the other hand, it will also better ensure the quality and safety of medicines, and promote the development of the entire pharmaceutical industry with better and higher quality.
.  

　　Original title: What impact will the acceleration of digital transformation of China's manufacturing industry have on the pharmaceutical industry?